Triple

T3582335
Position Surface form Disambiguated ID Type / Status
Subject Pacific Biosciences E75827 entity
Predicate product P490 FINISHED
Object Revio System
The Revio System is a high-throughput long-read DNA sequencing platform developed by Pacific Biosciences for comprehensive genomic analysis.
E371072 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Revio System | Statement: [Pacific Biosciences, product, Revio System]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Revio System
Context triple: [Pacific Biosciences, product, Revio System]
  • A. Chessie System
    Chessie System was a major American railroad holding company formed in the 1970s that operated several eastern U.S. railroads under the iconic “Chessie the cat” branding before eventually becoming part of CSX Transportation.
  • B. Invetech
    Invetech is a technology and product development company specializing in designing and engineering innovative medical and life science solutions.
  • C. Efficeon
    Efficeon is a family of low-power, x86-compatible microprocessors developed by Transmeta as the successor to its Crusoe line, aimed primarily at mobile and embedded computing devices.
  • D. Renflexis
    Renflexis is a biosimilar version of the monoclonal antibody infliximab, used to treat autoimmune conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
  • E. Enova SF
    Enova SF is a Norwegian state-owned enterprise that promotes energy efficiency, renewable energy, and reduced greenhouse gas emissions through funding and advisory programs.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Revio System
Triple: [Pacific Biosciences, product, Revio System]
Generated description
The Revio System is a high-throughput long-read DNA sequencing platform developed by Pacific Biosciences for comprehensive genomic analysis.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Revio System
Target entity description: The Revio System is a high-throughput long-read DNA sequencing platform developed by Pacific Biosciences for comprehensive genomic analysis.
  • A. Chessie System
    Chessie System was a major American railroad holding company formed in the 1970s that operated several eastern U.S. railroads under the iconic “Chessie the cat” branding before eventually becoming part of CSX Transportation.
  • B. Invetech
    Invetech is a technology and product development company specializing in designing and engineering innovative medical and life science solutions.
  • C. Efficeon
    Efficeon is a family of low-power, x86-compatible microprocessors developed by Transmeta as the successor to its Crusoe line, aimed primarily at mobile and embedded computing devices.
  • D. Renflexis
    Renflexis is a biosimilar version of the monoclonal antibody infliximab, used to treat autoimmune conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
  • E. Enova SF
    Enova SF is a Norwegian state-owned enterprise that promotes energy efficiency, renewable energy, and reduced greenhouse gas emissions through funding and advisory programs.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69ad85d6dc3c8190b491b79b83e25461 completed March 8, 2026, 2:21 p.m.
NER Named-entity recognition batch_69adc102cb2881908fa4dc1bf6fa5961 completed March 8, 2026, 6:33 p.m.
NED1 Entity disambiguation (via context triple) batch_69b402f36b2481909d4716e72a696e0d completed March 13, 2026, 12:28 p.m.
NEDg Description generation batch_69b403b9e7ac8190917e7313279b1c46 completed March 13, 2026, 12:31 p.m.
NED2 Entity disambiguation (via description) batch_69b4086f6da4819084778dffa33ef116 completed March 13, 2026, 12:51 p.m.
Created at: March 8, 2026, 3:21 p.m.